Skip to main navigation Skip to search Skip to main content

Neurocognitive impairment associated with alcohol use disorders: Implications for treatment

  • Marsha E. Bates
  • , Stephen C. Bowden
  • , Danielle Barry

Research output: Contribution to journalReview articlepeer-review

Abstract

Between 50% and 80% of individuals with alcohol use disorders experience mild to severe neurocognitive impairment. There is a strong clinical rationale that neurocognitive impairment is an important source of individual difference affecting many aspects of addiction treatment, but empirical tests of the direct influence of impairment on treatment outcome have yielded weak and inconsistent results. The authors address the schism between applied- theoretical perspectives and research evidence by suggesting alternative conceptual models of the relationship between neurocognitive impairment and addiction treatment outcome. Methods to promote neurocognitive recovery and ways in which addiction treatments may be modified to improve psychosocial adaptation are suggested. Specific suggestions for future research that may help clarify the complex relations between neurocognitive impairment and addiction treatment are outlined.

Original languageAmerican English
Pages (from-to)193-212
Number of pages20
JournalExperimental and Clinical Psychopharmacology
Volume10
Issue number3
DOIs
StatePublished - Aug 2002

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Neurocognitive impairment associated with alcohol use disorders: Implications for treatment'. Together they form a unique fingerprint.

Cite this